AtaiBeckley Inc. Financials

ATAI

All currency values in $ millions unless otherwise noted

Income Statement	TTM ~1.6:1 split	DEC 2025 ~1.4:1 split	DEC 2024
Revenues
Revenue	$5	$4	$0
General & Administrative	$58	$65	$48
Research & Development	$68	$53	$55
Other Operating Expenses	–	-$3	$6
Total Operating Expenses	$126	$648	$103
Operating Income	-$121	-$644	-$103
Non-Operating
Net Interest Expense	-$1	$0	-$2
Other Non-Operating Income (Expense)	$5	-$16	-$43
EBT (Earnings Before Tax)	-$116	-$660	-$148
Income Tax Expense	$0	$0	-$0
Minority Interest	-$0	-$0	-$1
Net Income
Net Income	-$116	-$660	-$149
Per Share Data
Revenue Per Share	$0.01	$0.02	$0.00
EPS (Basic)	-$0.46	-$2.91	-$0.93
EPS (Diluted)	-$0.46	-$2.91	-$0.93
Weighted Avg Shares (Basic)	360.8M	226.5M	160.2M
Weighted Avg Shares (Diluted)	360.8M	226.5M	160.2M
Shares Outstanding	360.8M	226.5M	160.2M

SourceFinancial statements computed from the 10-Q filed 7 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 12 Aug 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ATAI

CompareIntrinsic value

PRPHProPhase Labs Inc.

$0.01-42.00%0

CPHIChina Pharma Holdings Inc.

$0.59-3.28%15

MRKRMarker Therapeutics, Inc.

$1.01+3.06%25

CAMPCamp4 Therapeutics Corp.

$3.74-2.35%40

ENSCEnsysce Biosciences Inc.

$0.37-2.20%40

TXMDTherapeuticsMD, Inc.

$1.82+2.25%25

CLSDQClearside Biomedical, Inc.

No recent price10

UPBUpstream Bio, Inc.

$3.70+9.14%21

Held by ETFs

ATAI is in 19 US ETFs. The largest of them, with ATAI's weight in each:

Spot a number that looks wrong? Check it in ATAI's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ATAI

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.